Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash Mostaghimi

Showing results (231-240 of 339) with videos related to

Pageof 34
Sort By:
Journal of Psoriasis and Psoriatic Arthritis|May 5, 2026
Safety of IL-17A Inhibitors in Patients With Moderate to Severe Psoriasis in a US Claims Data-Based Cohort StudyMaria C Schneeweiss, Joseph F Merola, Yinzhu Jin, et al.
JAAD International|December 1, 2025
Quantifying the risk of drug-associated skin hyperpigmentation relative to the general population: A national cohort study using TriNetXDebby Cheng, Helen Ji, David Xiang, et al.
Dermatology Research and Practice|July 19, 2018
Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional StudyDavid G Li, Fan Di Xia, Jasmine Rana, et al.
Plos One|June 7, 2018
Development and pilot-testing of the Alopecia Areata Assessment Tool (ALTO)David G Li, Kathie P Huang, Fan Di Xia, et al.
Archives of Dermatological Research|October 23, 2022
Evaluation of Dundee and ALT-70 predictive models for cellulitis in 56 patients who underwent tissue cultureTrent D Walker, Ty W Gilkey, John Christopher Trinidad, et al.
Dermatology Research and Practice|August 26, 2022
Development and Validation of a Simple Model to Predict the Risk of Nonmelanoma Skin Cancer on Screening Total Body Skin ExaminationRebecca I Hartman, Yun Xue, Ryan Karmouta, et al.
Journal of Medical Economics|March 10, 2023
Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United StatesWei Gao, Arash Mostaghimi, Kavita Gandhi, et al.
Archives of Dermatological Research|November 29, 2022
Limb amputation in patients with pyoderma gangrenosum: a multi-institutional case seriesHadir Shakshouk, Julia S Lehman, Bicong Wu, et al.
Journal of the American Academy of Dermatology|July 2, 2022
Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoidJordan T Said, Jordan Talia, Erin Wei, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Differences in risk of tetracycline-associated hyperpigmentation between racial and ethnic groups in patients with acne vulgaris: A national US retrospective studyKatherine Young, Angel D Pagan, Jaewon Yoon, et al.
Pageof 34

Showing results (231-240 of 339) with videos related to

Sort By:
Pageof 34
Journal of Psoriasis and Psoriatic Arthritis|May 5, 2026
Safety of IL-17A Inhibitors in Patients With Moderate to Severe Psoriasis in a US Claims Data-Based Cohort StudyMaria C Schneeweiss, Joseph F Merola, Yinzhu Jin, et al.
JAAD International|December 1, 2025
Quantifying the risk of drug-associated skin hyperpigmentation relative to the general population: A national cohort study using TriNetXDebby Cheng, Helen Ji, David Xiang, et al.
Dermatology Research and Practice|July 19, 2018
Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional StudyDavid G Li, Fan Di Xia, Jasmine Rana, et al.
Plos One|June 7, 2018
Development and pilot-testing of the Alopecia Areata Assessment Tool (ALTO)David G Li, Kathie P Huang, Fan Di Xia, et al.
Archives of Dermatological Research|October 23, 2022
Evaluation of Dundee and ALT-70 predictive models for cellulitis in 56 patients who underwent tissue cultureTrent D Walker, Ty W Gilkey, John Christopher Trinidad, et al.
Dermatology Research and Practice|August 26, 2022
Development and Validation of a Simple Model to Predict the Risk of Nonmelanoma Skin Cancer on Screening Total Body Skin ExaminationRebecca I Hartman, Yun Xue, Ryan Karmouta, et al.
Journal of Medical Economics|March 10, 2023
Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United StatesWei Gao, Arash Mostaghimi, Kavita Gandhi, et al.
Archives of Dermatological Research|November 29, 2022
Limb amputation in patients with pyoderma gangrenosum: a multi-institutional case seriesHadir Shakshouk, Julia S Lehman, Bicong Wu, et al.
Journal of the American Academy of Dermatology|July 2, 2022
Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoidJordan T Said, Jordan Talia, Erin Wei, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Differences in risk of tetracycline-associated hyperpigmentation between racial and ethnic groups in patients with acne vulgaris: A national US retrospective studyKatherine Young, Angel D Pagan, Jaewon Yoon, et al.
Pageof 34